SMS Lifesciences India has informed that the meeting of the Board of Directors of the Company has been scheduled on Friday, February 14, 2020, to consider and approve, the Unaudited Financial Results for the 3rd quarter and nine months ended December 31, 2019. In view of the SEBI (PIT) Regulations, 2015 as amended and in continuation to its letter dated December 31,2019 with respect to closure of trading window of the Company, the Trading Window for dealing in the shares of the Company by the insiders has been closed from January 1, 2020 to February 16, 2020.
The above information is a part of company's filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1806.70 |
| Dr. Reddys Lab | 1267.00 |
| Cipla | 1385.90 |
| Zydus Lifesciences | 1103.00 |
| Lupin | 2289.00 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: